Oncology & Cancer

Nexavar approval expanded for common thyroid cancer

(HealthDay)—U.S. Food and Drug Administration approval for the anti-cancer drug Nexavar (sorafenib) has been expanded to include late-stage differentiated thyroid cancer, the most common type of thyroid cancer.

Oncology & Cancer

Blood-pressure drug may help improve cancer treatment

Use of existing, well-established hypertension drugs could improve the outcome of cancer chemotherapy by opening up collapsed blood vessels in solid tumors. In their report in the online journal Nature Communications, Massachusetts ...

Diabetes

Approved cancer drug potentially could help treat diabetes

A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pathway—a series of interaction among proteins—involved in the development of diabetes. Furthermore, they have ...

page 20 from 28